Medical Radioisotopes
Medical radioisotopes are analyzed by isotope and use, covering diagnostic isotopes for SPECT and PET imaging and therapeutic isotopes for radioligand therapy. Reactor and cyclotron…
Precision oncology is examined as a technology field that matches treatment to the molecular profile of each tumor. Genomic profiling, companion diagnostics, tumor boards, decision-support tools and targeted therapy access are covered across care settings and regions.
The study gives estimates and forecasts for the global market and for each major region, with country-level analysis where the market warrants it. It profiles the companies that matter in this field and lists the wider supplier base in a corporate directory, together with recent product launches, partnerships, collaborations, mergers and acquisitions.
Strategists, investors, laboratories, contract research and manufacturing organizations, biotechnology and healthcare companies, academic professionals and regulatory teams use our reports to
The full table of contents and list of exhibits come with the sample pages. Request sample pages.
Reports are delivered as a PDF by email within one working day of payment. Payment by invoice. Read the license terms and terms of sale.
Ask for sample pages, a formal quotation for your purchasing team, or put a question to the analyst. Sample pages are sent to organization email addresses only.
Medical radioisotopes are analyzed by isotope and use, covering diagnostic isotopes for SPECT and PET imaging and therapeutic isotopes for radioligand therapy. Reactor and cyclotron…
Brachytherapy sources are studied by isotope and dose rate, covering high-dose-rate, low-dose-rate and pulsed-dose-rate seeds and sources. Prostate, cervical, breast and skin cancer…
MRD monitoring is analyzed by method, including next-generation sequencing, flow cytometry and PCR, across hematologic cancers and solid tumors. The report covers tumor-informed and…
Immuno-oncology is studied across checkpoint inhibitors, cancer vaccines, cell therapies and immune agonists. The report covers approved therapies, combination strategies, the clinical…